// App-Quantinova.ai

65 : SUMMACTA: A Randomized, Double-Blind, Parallel Group Study of the Safety and Efficacy of Tocilizumab SC versus Tocilizumab IV, in Combination with Traditional DMARDs in Patients with Moderate to Severe RA

Researchers

Presenter

  • Andrea Rubbert-Roth

Principal Investigators

  • Alain Cantagrel

  • Ivana Vranic

  • Gerd Burmester

  • Stephen Hall

  • Piotr Leszczynski

  • Daniel Feldman

  • Madura Rangaraj

  • Georgia Roane

  • Charles Ludivico

  • Eduardo Mysler

  • Lucy Rowell

Medical Centers

  • Brustzentrum Charite-Universitatsmedizin, Berlin, Germany

  • Klinikum der Universitat zu Koln, Cologne, Germany

  • Saskatoon Osteoporosis Centre, Saskatoon,Canada

Locations

  • France

  • Germany

  • Canada

Companies

  • F. Hoffmann-La Roche

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

Outcome

  • Unknown

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved